Cosmos Health (COSM) Research & Development (2019 - 2026)

Cosmos Health (COSM) has reported Research & Development for 8 consecutive years, with $98226.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Research & Development rose 31.6% year-over-year to $98226.0; the trailing twelve-month figure through Jun 2026 stood at $587080.0 (up 66.95% YoY), and the FY2025 full-year result was $519363.0, down 2.61% from the prior year.
• Research & Development grew to $98226.0 in Q2 2026 per COSM's latest filing, from $19352.0 in the prior quarter.
• Across five years, Research & Development topped out at $467263.0 in Q1 2023 and bottomed at $19352.0 in Q1 2026.
• Historically, Research & Development has averaged $169881.0 across 5 years, with a median of $140317.5 in 2022.
• The sharpest annual moves came in 2023 and 2025: Research & Development jumped 217.98% in 2023, then sank 83.78% in 2025.
• Over 5 years, Research & Development stood at $133686.0 in 2022, then jumped by 95.89% to $261877.0 in 2023, then dropped by 20.95% to $207002.0 in 2024, then surged by 95.51% to $404708.0 in 2025, then sank by 75.73% to $98226.0 in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $98226.0, $19352.0, and $404708.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.